Alterations in secreted protein-regulated signaling pathways (e.g., leptin, adiponectin, IL-6) have been associated with increased susceptibility to obesity-associated metabolic disorders such as type 2 diabetes (T2D)2–5. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.